Dopamine Blocker Restores Blood Sugar Awareness in Diabetes
New research reveals how dopamine antagonists could prevent dangerous hypoglycemia unawareness in diabetic patients.
Cardiovascular disease prevention, blood pressure, cholesterol, and heart function
619 artigos
New research reveals how dopamine antagonists could prevent dangerous hypoglycemia unawareness in diabetic patients.
Researchers discover how cancer cells use metabolic enzyme PHGDH to evade immune detection, opening new combination therapy approaches.
Major trial shows evolocumab reduces cardiovascular events by 22% in diabetic patients, offering new prevention strategy.
New study shows evolocumab significantly reduces cardiovascular events in diabetes patients, offering powerful prevention strategy.
Major cardiology groups recommend cholesterol screening in childhood for some, plus new genetic risk factors like lipoprotein(a) testing.
Leading cardiologists highlight persistent challenges in determining optimal lipid-lowering strategies for cardiovascular disease prevention.
The Lancet announces comprehensive commission to address the growing global burden of colorectal cancer through prevention and treatment strategies.
New analysis challenges assumptions about sudden cardiac death risk in heart failure patients with preserved pumping ability.
Major study shows tirzepatide reduces cardiovascular and kidney complications by 16% compared to dulaglutide in diabetic patients.
Neurofilament light chain levels in blood strongly predict cardiovascular events and death in people with atrial fibrillation over 8 years.

Post-analysis of major trial shows extended apixaban treatment may prevent superficial vein thrombosis in patients with ongoing clotting risks.
Women who experience spontaneous coronary artery dissection during pregnancy face worse heart damage and slower recovery than non-pregnant cases.